H. Lundbeck
Connections
Around the web
-
Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013
NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: GlobalData's clinical trial report, "Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013" provides data on the L from PR Newswire Read more »
-
Lundbeck makes Selincro available in Norway, Finland, Poland, Baltic markets
H. Lundbeck has introduced the first approved medication reducing alcohol consumption in alcohol dependent patients in Norway, Finland, Poland and the Baltic markets. Additional launches in other European countries are expected to follow later in 2013 an from Pharmaceutical Business Review Read more »
-
Double Jeopardy for H Lundbeck - Escitalopram SPC back in Court and no speedy Resolution
This Kat must have been in bed the day that they taught about privity, so his whiskers twitched at such a clear exposition of the concept and the jurisprudence set out at length and in detail by Arnold J. As is his custom, this Kat records that the decis from The IPKat Read more »
-
Lundbeck announces positive results for Brintellix™ (vortioxetine)
H. Lundbeck A/S (Lundbeck) today announced positive results for the REVIVE study, a double-blind randomized study of Brintellix™ (vortioxetine) versus agomelatine in adults with major depression (MDD) who changed antidepressant treatment after an inadequ from World Pharma News Read more »
-
BRIEF-Lundbeck announces positive results for Brintellix
STOCKHOLM, April 8 (Reuters) - H Lundbeck A/S : * Lundbeck announces positive results for brintellix (vortioxetine) in adult patients with major depression and inadequate response to ssri or snri This discussion is now closed. We welcome comments on our from Reuters Read more »
